Toxicoproteomics -- a new preclinical tool.
The publication of the human genome has presented the scientific community with an unprecedented amount of genetic information with the potential to revolutionize the drug discovery process. This information could be used to identify novel drug targets and disease markers or could aid in the develop...
Κύριοι συγγραφείς: | Bandara, L, Kennedy, S |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2002
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Toxicoproteomic Profiling of <i>hPXR</i> Transgenic Mice Treated with Rifampicin and Isoniazid
ανά: Christopher Trent Brewer, κ.ά.
Έκδοση: (2020-07-01) -
Digging Deeper Into the Pyriproxyfen-Response of the Amphipod Gammarus fossarum With a Next-Generation Ultra-High-Field Orbitrap Analyser: New Perspectives for Environmental Toxicoproteomics
ανά: Judith Trapp, κ.ά.
Έκδοση: (2018-06-01) -
Toxicoproteomics Disclose Pesticides as Downregulators of TNF-α, IL-1β and Estrogen Receptor Pathways in Breast Cancer Women Chronically Exposed
ανά: Luciana Pizzatti, κ.ά.
Έκδοση: (2020-08-01) -
In vitro toxicoproteomic analysis of A549 human lung epithelial cells exposed to urban air particulate matter and its water-soluble and insoluble fractions
ανά: Ngoc Q. Vuong, κ.ά.
Έκδοση: (2017-10-01) -
Ex Vivo Metrics™, a preclinical tool in new drug development
ανά: Bilyard Kevin, κ.ά.
Έκδοση: (2008-01-01)